CeramTec receives FDA Breakthrough Device designation for novel ceramic knee project
The U.S. Food & Drug Administration (FDA) has confirmed that CeramTec’s novel ceramic total knee replacement device and proposed indication for use meet the criteria of a Breakthrough Device.
